WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
| B. Riley Securities 25th Annual Investor Conference | |
| Date: | Thursday, May 22, 2025 |
| Format: | 1x1 Meetings & Fireside Chat |
| Location: | The Ritz-Carlton, Marina del Rey |
| Stifel 2025 Boston Cross Sector 1x1 Conference | |
| Date: | Tuesday, June 3, 2025 |
| Format: | 1x1 Meetings |
| Location: | InterContinental Boston |
| 45th Annual William Blair Growth Stock Conference | |
| Date: | Thursday, June 5, 2025 |
| Format: | 1x1 Meetings |
| Location: | Loews Chicago Hotel |
| The Citizens Medical Devices and Healthcare Services Forum | |
| Date: | Tuesday, June 17, 2025 |
| Format: | 1x1 Meetings |
| Location: | Boston Harbor Hotel |
To request a meeting or for more details about the conferences please reach out to your institutional contact.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$18.13 |
| Daily Change: | -0.11 -0.60 |
| Daily Volume: | 135,749 |
| Market Cap: | US$336.580M |
August 07, 2025 May 12, 2025 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
